Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application

Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application

Atherosclerosis (AS) is the leading cause of stroke and death worldwide. Although many lipid-lowering or antiplatelet medicines have been used to prevent the devastating outcomes caused by AS, the serious side effects of these medicines cannot be ignored. Moreover, these medicines are aimed at preve...

Full description

Bibliographic Details
Main Authors: Yandong Liu, Futang Yang, Sili Zou, Lefeng Qu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Pharmacology
Subjects:
atherosclerosis
cardiovascular disease
inflammation
immune response
autophagy
rapamycin
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.01520/full

Similar Items

Similar Items